Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-221-0 | CAS number: 3033-77-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
No data was available.
Effect on fertility: via oral route
- Dose descriptor:
- NOAEL
- 10 mg/kg bw/day
Additional information
There are no studies conducted on toxicity to fertility. Some information of the effect on the morphology of the gonads can be obtained from the 28-day test conducted with Wistar rats. The rats were administered by oral gavage 0, 3.16, 10.0, 31.6 or 100 mg/kg EPTAC (72.6 %) for 28 days (Degussa, 1990). The control and high dose group had 10 males and 10 female and the low- and mid-dose groups had five rats of each sex. Five high dose and five control group animals were submitted to a 4-week post-exposure observation period. The study was conducted under GLP regulations and OECD guideline 407 was followed as the study protocol. See section 7.5.1 "3033 -77 -0 Repeated dose toxicity: oral/2008/EURA" for a more complete description of the study.
Male rats of the highest dose groups had a significant decrease (-35-40%) of the testis weight at week 5, which remained significantly lower in the recovery group at week 9. The female ovaries showed a weight decrease trend at week 5, where the weight difference was significant in the dose groups 31.6 mg/kg and 100 mg/kg. However, at week 9 in the recovery group, there was significant ovary weight decrease (max 60%) in the right ovary only in the 100 mg/kg dose group. Microscopically, males of the 31.6 and 100 mg/dose groups showed a dose-related incidence and severity of focal atrophy of the testes. Females had a dose dependent severity of follicular atrophy and persistent corpora lutea in the 31.6 and 100 mg/kg dose groups. The uterus epithelium was atrophic and morphologically in anoestrus. The changes in the gonads persisted in both sexes through the recovery period. The body weight in the 100 mg/kg group males at day 28 was about 45% lower than the control group and in the 31.6 mg/kg group at that time the mean body weight was about 18% lower and in the 10 mg/kg group a 12 % reduction was noted. The 100 mg/kg dose females had about 38 % lower mean body weight than the control. No significant difference was noted in other groups or in the recovery group. After the recovery period, the male 100 mg/kg recovery group had still about 29% lower mean body weight, when compared to control.
Although these results tell little of the effect on the reproductive performance itself they can be used to set an indicative NOAEL based on the rather severe morphological changes in the reproductive organs of both sexes. The 10 mg/kg NOAEL obtained from the 28-day repeated dose toxicity study is selected for toxicity to reproduction. EPTAC is therefore classified as Repr.2, H361f (Suspected of damaging fertility) according to the criteria of the CLP regulation (No 1272/2008) and as Repr. Cat. 3; R62 (Possible risk of impaired fertility) according to the criteria of Directive 67/548/EEC.
Short description of key information:
The 10 mg/kg NOAEL obtained from the 28-day repeated dose toxicity study is selected for toxicity to reproduction (OECD 407, Kr:2).
Effects on developmental toxicity
Description of key information
No data was available.
Additional information
No data was available
Toxicity to reproduction: other studies
Additional information
No data was available.
Justification for classification or non-classification
Harmonised classification:
EPATC is classified as Repr.2, H361f (Suspected of damaging fertility) in the Annex VI, Table 3.1 of the CLP regulation (No 1272/2008) and as Repr. Cat. 3; R62 (Possible risk of impaired fertility) in the Annex VI, Table 3.2 of the CLP regulation (1272/2008).
No additionnal self-classification is proposed
Developmental toxicity/teratogenicity:
No self-classification is proposed due to lack of data.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.